82
Views
0
CrossRef citations to date
0
Altmetric
AOAAM Contribution

President’s message

, DO, FAOAAMORCID Icon

References

  • Atkinson TJ, Schatman ME, Fudin J. The damage done by the war on opioids: the pendulum has swung too far. J Pain Res. 2014;7:265–8. doi:10.2147/JPR.S65581.
  • Comerci G, Jr, Katzman J, Duhigg D. Controlling the swing of the opioid pendulum. N Engl J Med. 2018;378(8):691–3. doi:10.1056/NEJMp1713159.
  • Evans CB. A tragic swing of the pendulum in the opioid crisis. Pain Manag Nurs. 2018;19(3):205–6. doi:10.1016/j.pmn.2018.03.004.
  • Barry HC. Balancing needs and risks as the opioid pendulum swings. J Fam Pract. 2023;72(4):148–82. doi:10.12788/jfp.0598.
  • U.S. Opioid Dispensing Rate Maps 2006 to 2020. 2021 Nov 10 [accessed 2023 October 8] https://www.cdc.gov/drugoverdose/rxrate-maps/index.html.
  • Paulozzi LJ, Mack KA, Hockenberry JM, Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States. 2012; MMWR Morb Mortal Wkly Rep. 2014. 63(26):563–8.
  • Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Netw Open. 2019;2(1):e186007. doi:10.1001/jamanetworkopen.2018.6007.
  • Baker DW. History of The Joint Commission’s Pain Standards: essons for today’s prescription opioid epidemic. JAMA. 2017;317(11):1117–8. doi:10.1001/jama.2017.0935.
  • Alpert JS. The Vioxx debacle. Am J Med. 2005;118(3):203–4. doi:10.1016/j.amjmed.2005.01.020.
  • Drazen JM. COX-2 inhibitors–a lesson in unexpected problems. N Engl J Med. 2005;352(11):1131–2. doi:10.1056/NEJMe058038.
  • Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634–42. doi:10.1161/CIRCULATIONAHA.106.181424.
  • Xu J, Kochanek KD, Murphy SL, Arias E. Mortality in the United States. NCHS Data Brief. 2012;2014(168):1–8.
  • Ahmad FB, Cisewski JA, Xu J, Anderson RN. Provisional mortality data - United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(18):488–92. Published 2023 May 5. doi:10.15585/mmwr.mm7218a3.
  • Lindsley CW. 2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions. ACS Chem Neurosci. 2013;4(8):1133–5. doi:10.1021/cn400127u.
  • Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76. doi:10.1097/01.j.pain.0000460357.01998.f1.
  • Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, et al. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions-III. JAMA Psychiatry. 2016;73(1):39–47. doi:10.1001/jamapsychiatry.2015.2132.
  • Coffin PO, Barreveld AM. Inherited patients taking opioids for chronic pain - considerations for primary care. N Engl J Med. 2022;386(7):611–3. doi:10.1056/NEJMp2115244.
  • Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285–7. Epub 2019 Apr 24. doi:10.1056/NEJMp1904190.
  • Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, Robinson A, Paik M, Sandbrink F, Gordon AJ, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020;368:m283. doi:10.1136/bmj.m283.
  • Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022;(457):1–8. doi:10.15620/cdc:122556.
  • Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. doi:10.1136/bmj.j1550.
  • Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, Weiner JP, Saloner B. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction. 2020;115(9):1683–94. doi:10.1111/add.14991.
  • Watts BV, Gottlieb DJ, Riblet NB, Gui J, Shiner B. Association of medication treatment for opioid use disorder with suicide mortality. Am J Psychiatry. 2022;179(4):298–304. doi:10.1176/appi.ajp.2021.21070700.
  • Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi:10.1016/j.drugpo.2022.103786.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.